Expression of maspin in colorectal cancer

In Vivo

Volumn 20, Issue 6 B, 2006, Pages 797-800

  Umekita, Yoshihisa ^a   Souda, Masakazu ^a   Hiroki, Yoshida ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

Author keywords

Colorectal cancer; Immunohistochemistry; Maspin; Tumor budding

Indexed keywords

MASPIN; SERINE PROTEINASE INHIBITOR; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER GRADING; CANCER INVASION; CANCER STAGING; COLON ADENOCARCINOMA; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; PROTEIN EXPRESSION; PROTEIN FAMILY; RECTUM CARCINOMA; TUMOR DIFFERENTIATION; TUMOR VASCULARIZATION;

EID: 33846072167     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Zou Z, Aniscowicz A, Hendrix MJ, Thor A, Neveu M, Sheng S, Rafidi K, Seftor E and Sager R: Maspin, a serpin with tumor-suppressing activity in human mammary epithelilal cells. Science 263: 526-529, 1994.
2. Carethers JM, Hawn MT, Greenson JK, Hitchcock CL and Boland CR: Prognostic significance of allelic loss at chromosome 18q21 for stage II colorectal cancer. Gastroenterology 114: 1188-1195, 1998.
3. Sood AK, Fletcher MS, Gruman LM, Coffin JE, Jabbari S, Khalkhali-Ellis Z, Arbour N, Seftor EA and Hendrix MJ: The paradoxical expression of maspin in ovarian carcinoma. Clin Cancer Res 8: 2924-2932, 2002.
4. Umekita Y, Ohi Y, Sagara Y and Yoshida H: Expression of maspin predicts poor prognosis in breast-cancer patients. Int J Cancer 100: 452-455, 2002.
5. Mohsin SK, Zhang M, Clark GM and Craig Allred D: Maspin expression in invasive breast cancer: association with other prognostic factors. J Pathol 199: 432-435, 2003.
6. Hirai K, Koizumi K, Haraguchi S, Hirata T, Mikami I, Fukushima M, Yamagishi S, Kawashima T, Okada D, Shimizu K and Kawamoto M: Prognostic significance of the tumor suppressor gene maspin in non-small cell lung cancer. Ann Thorac Surg 79: 248-253, 2005.
7. Stanley R, Hamilton R and Aaltonen LA (eds.): World Health Organization Classification of Tumours. Pathology and Genetics, Tumours of the Digestive System. Lyon, France, IARCPress, pp. 104-109, 2000.
8. Ueno H, Murphy J, Jass JR, Moehizuki H and Talbot IC: Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40: 127-132, 2002.
9. Sheng S, Carey J, Seftor EA, Dias L, Hendrix MJC and Sagar R: Maspin acts at the cell membrane to inhibit invasion and motility of mammary and prostatic cancer cells. Proc Natl Acad Sci USA 93: 11669-11674, 1996.
10. Maass N, Hojo T, Rosel F, Ikeda T, Jonat W and Nagasaki K: Down regulation of the tumor suppressor gene maspin in breast carcinoma is associated with a higher risk of distant metastasis. Clin Biochem 34: 303-307, 2001.
11. Maass N, Teffner M, Rosel F, Pawaresch R, Jonat W, Nagasaki K and Rudolph P: Decline in the expression of serine protease inhibitor maspin is associated with tumor progression in ductal carcinomas of the breast. J Pathol 195: 321-326, 2001.
12. Umekita Y and Yoshida H: Expression of maspin is up-regulated during the progression of mammary ductal carcinoma. Histopathology 42: 541-545, 2003.
13. Terashima M, Maesawa C, Oyama K, Ohtani S, Akiyama Y, Ogasawara S, Takagane A, Saito K, Masuda T, Kanzaki N, Matsuyama S, Hoshino Y, Kogure M, Gotoh M, Shirane M and Mori K: Gene expression profiles in human gastric cancer. Expression of maspin correlates with lymph node metastasis. Br J Cancer 92: 1130-1136, 2005.
14. Maass N, Hojo T, Ueding M, Luttges J, Kloppel G, Jonat W and Nagasaki K: Expression of the tumor suppressor gene maspin in human pancreatic cancers. Clin Cancer Res 7: 812-817, 2001.
15. Ito Y, Yoshida Y, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Matsuura N, Kuma K and Miyauchi A: Maspin expression is directly associated with biological aggressiveness of thyroid carcinoma. Thyroid 14: 132-138, 2004.
16. Song SY, Lee SK, Kim DH, Son HJ, Kim HJ, Lira YJ, Lee WY, Chun HK and Rhee JC: Expression of maspin in colon cancers. Its relationship with p53 expression and microvessel density. Dig Dis Sci 47: 1831-1835, 2002.
17. Boltze C: Loss of maspin is a helpful prognosticator in colorectal cancer: a tissue microarray analysis. Pathol Res Pract 200: 783-790, 2005.
18. Umekita Y, Hiipakka RA and Liao S: Rat and human maspin; structures, metastatic suppressor activity and mutation in prostate cancer cells. Cancer Letters 113: 87-93, 1997.
19. Bettstetter M, Woenckhaus M, Wild PJ, Rummele P, Blaszyk H, Hartmann A, Hofstadter F and Dietmaier W: Elevated nuclear maspin expression is associated with microsatellite instability and high tumour grade in colorectal cancer. J Pathol 205: 606-614, 2005.
20. Park KJ, Choi HJ, Roh MS, Kwon HC and Kim C: Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis Colon Rectum 48: 1597-1602, 2005.